Excessive daytime sleepiness in Parkinson's disease.
Schapira
Anthony H
AH
The Royal Free and University College Medical School, University College London, and Institute of Neurology, University College London, London, United Kingdom. schapira@rfc.ucl.ac.uk
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D048909:Diabetes Complications / Q000453:epidemiology; D006970:Disorders of Excessive Somnolence / Q000453:epidemiology / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D015995:Prevalence; D011446:Prospective Studies; D020919:Sleep Disorders, Intrinsic / Q000209:etiology / Q000503:physiopathology; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology / Q000503:physiopathology; D011795:Surveys and Questionnaires
D000978:Antiparkinson Agents; D018491:Dopamine Agonists